Akova Yonca A, Küçükerdönmez Cem, Gedik Sansal
Baskent University Faculty of Medicine, Department of Ophthalmology, 10. Sokak No:45 Bahçelievler, 06490 Ankara, Turkey.
Ophthalmic Surg Lasers Imaging. 2006 May-Jun;37(3):204-11. doi: 10.3928/15428877-20060501-04.
To evaluate the results of phacoemulsification and posterior chamber intraocular lens (IOL) implantation in patients with uveitis.
Review of records of 37 eyes of 31 patients with uveitis (14 men and 17 women; mean age, 49.8 years; age range, 26 to 71 years) who underwent phacoemulsification with IOL implantation. The data recorded were age, gender, IOL type, treatment modalities, final visual outcome, and complications.
Panuveitis, anterior uveitis, posterior uveitis, and intermediate uveitis were detected in 16 (51.6%), 9 (29.0%), 5 (16.1%), and 1 (3.3%) of the patients, respectively. At 6 months postoperatively, 32 (86.5%) eyes had achieved a best-corrected visual acuity of 20/40 or better, and 22 (59.5%) eyes had a visual acuity of 20/20. Five (13.5%) eyes showed limited improvement in postoperative visual acuity due to posterior segment problems. Postoperative recurrence of inflammation occurred in 12 eyes (32.4%) of 10 patients and was treated and controlled with medical therapy.
When inflammation in uveitic eyes is under complete control, phacoemulsification and implantation of a foldable acrylic IOL in the posterior chamber is safe, effective, and tolerated well. To minimize vision-limiting complications, these patients must be observed closely after surgery, and must be treated aggressively if the inflammation recurs.
评估葡萄膜炎患者白内障超声乳化吸除联合后房型人工晶状体（IOL）植入术的效果。
回顾31例葡萄膜炎患者（男14例，女17例；平均年龄49.8岁，年龄范围26至71岁）37只眼行白内障超声乳化吸除联合IOL植入术的记录。记录的数据包括年龄、性别、IOL类型、治疗方式、最终视力结果及并发症。
分别在16例（51.6%）、9例（29.0%）、5例（16.1%）和1例（3.3%）患者中检测到全葡萄膜炎、前葡萄膜炎、后葡萄膜炎和中间葡萄膜炎。术后6个月时，32只眼（86.5%）最佳矫正视力达到20/40或更好，22只眼（59.5%）视力达到20/20。5只眼（13.5%）因后段问题术后视力改善有限。10例患者的12只眼（32.4%）出现术后炎症复发，经药物治疗得以控制。
当葡萄膜炎性眼的炎症得到完全控制时，后房型折叠式丙烯酸酯IOL植入的白内障超声乳化吸除术是安全、有效的，且耐受性良好。为使视力受限并发症降至最低，术后必须密切观察这些患者，炎症复发时必须积极治疗。
